Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Deferred Taxes came in at $17.0 million in Q2 2026, up 140.48% year-over-year from $7.1 million in Q2 2025, and down 43.33% quarter-over-quarter from $30.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Deferred Taxes across 18 years of filings, most recently posting $17.0 million for Q2 2026.
- In Q2 2026, Deferred Taxes rose 140.48% year-over-year to $17.0 million; the TTM figure through Jun 2026 stood at $178.0 million (up 53.45% YoY), while the FY2025 annual figure was $80.0 million, up 21.21% from the prior year.
- Deferred Taxes came in at $17.0 million for Q2 2026 at Bausch Health Companies, down from $30.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $170.0 million in Q4 2024 to a low of -$96.0 million in Q3 2022.
- Average Deferred Taxes over 5 years is $4.0 million, with a median of -$9.0 million recorded in 2025.
- Year-over-year, Deferred Taxes plunged 700.0% in 2025 and jumped 433.33% in 2026.
- Over 5 years, Deferred Taxes stood at $19.0 million in 2022, then soared by 342.11% to $84.0 million in 2023, then soared by 102.38% to $170.0 million in 2024, then dropped by 8.82% to $155.0 million in 2025, then sank by 89.03% to $17.0 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $17.0 million in Q2 2026, $30.0 million in Q1 2026, and $155.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 25.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -124.50 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 17.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 59,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -4.94 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.00 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 155.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Mar 31, 2025 | -9.00 Mn |
| Dec 31, 2024 | 170.00 Mn |
| Sep 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -44.00 Mn |
| Mar 31, 2024 | -57.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -30.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | -96.00 Mn |
| Jun 30, 2022 | -16.00 Mn |
| Mar 31, 2022 | -83.00 Mn |
| Dec 31, 2021 | -88.00 Mn |
| Sep 30, 2021 | -17.00 Mn |
| Jun 30, 2021 | -106.00 Mn |